From 100 mg up to 100 g scale mRNA synthesis for use from R&D to pre-GMP and GMP
Strong know-how on mRNA process to produce high integrity high purity mRNA drug substance
Efficient and stable process to achieve high IVT yield upstream and high recovery rate downstream
CATUG in-house technology for dsRNA removal could dramatically reduce the immunogenicity of mRNA therapeutics
In-house high throughput IVT synthesis and purification for early R&D mRNA screening
Over 50 in-house analytical methods for mRNA DS and DP release testing and quality research
CATUG in-house process and equipment for large-scale (up to 100g) mRNA encapsulation process
Collaboration with PNI on microfluidic mixing process supporting from early R&D to cGMP LNP production
From 1 mg up to 100 g mRNA encapsulation for use from R&D to pre-GMP and GMP
Strong expertise in LNP formulation study and in vitro/vivo screening for early R&D
Provide customized DoE studies during process development for better mixing outcomes and stable products
Let CATUG be your trusted partner for mRNA therapeutics development.
